RecruitingPriority 4 · Lower priorityNCT07003100
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Plain-language summary
This trial is testing Non-Interventional Study for patients with cutaneous T-cell lymphoma (CTCL), including mycosis fungoides or Sézary syndrome whose disease has come back or stopped responding to prior treatment. Researchers want to learn whether this approach can help control the lymphoma. This trial is available at 10 locations in the United States. The trial is currently recruiting patients.
Who can join (key eligibility)
- Age 18 Years or older
- Lymphoma came back or did not respond to prior treatment
Final eligibility is determined by the trial team. This list is a starting point only.
What's being tested
Non-Interventional Study (OTHER): Non-interventional study
Non-Interventional Study
- Treatment length
- Ask the trial team for details
- Visit frequency
- Ask the trial team for details